100
NPS Score
VS
Karyopharm Therapeutics Claimed Company
- This companyis accepting feedback from verified employeesEMPLOYEE
PARTICIPANTS - 90
- TOTAL
RATINGS
Vertex Pharmaceuticals Claimed Company
- EMPLOYEE
PARTICIPANTS - 80
- TOTAL
RATINGS
Karyopharm Therapeutics vs Vertex Pharmaceuticals
Compare Karyopharm Therapeutics versus Vertex Pharmaceuticals for CEO Rating, Overall Culture Score, Brand Ranking, and other ratings. Results were generated by 90 employees and customers of Karyopharm Therapeutics and 80 employees and customers of Vertex Pharmaceuticals.
Karyopharm Therapeutics
Karyopharm Therapeutics's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of Karyopharm Therapeutics. Their current market cap is $753.30M.
Vertex Pharmaceuticals
Vertex Pharmaceuticals's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of Vertex Pharmaceuticals. Their current market cap is $89.62B.
5/5
Product Quality
3.5/5
5/5
Pricing
4/5
5/5
Customer Service
3.9/5
| 100% | Promoters |
|---|---|
| 0% | Passive |
| 0% | Detractors |
Net Promoter Score
Winner by 66
34
NPS Score
| 59% | Promoters |
|---|---|
| 16% | Passive |
| 25% | Detractors |
See how Karyopharm Therapeutics compares to its competitors
Working at Karyopharm Therapeutics vs Working at Vertex Pharmaceuticals
82 / 100
Tied
82 / 100
Tied
Karyopharm Therapeutics
Karyopharm Therapeutics doesn't have enough ratings to calculate the Team Culture Ratings.
Know someone that works there? Invite them to rate their experience.
Vertex Pharmaceuticals
Employees at Vertex Pharmaceuticals rate their CEO, Reshma Kewalramani, 82/100. This score is 0% lower than the scores of Karyopharm Therapeutics' CEO, Richard Paulson. Employees in the HR and Finance departments rate Reshma Kewalramani the highest.